TeleMRPA was conceived considering the enormous number of hypertensive patients in Brazil (estimated at more than 40 million), the high frequency of diagnostic errors inherent to the in-office measurement and the need for outside monitoring, according to Brazilian and international guidelines.
The method was developed for large-scale application, so it should be simple, well tolerated by the patient, with an agile report, and as important as it was low cost, so that it could be applied even by public network, in order to adequately assist the entire hypertensive population in Brazil, reducing their morbidity and mortality.
Hypertension is the most prevalent disease in Brazil. According to the Vigitel Study of the Ministry of Health, released in 2017, slightly more than 25% of Brazilian adults declared to have a medical diagnosis of hypertension. Prevalence increases with age, ranging from 4% in individuals aged 18-24 years to 64% in those aged 65 years or older.
These numbers alone are frightening, but we know that a significant percentage of hypertensive people do not know they are carriers of the disease.